BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 11105300)

  • 21. A randomised open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy.
    Reunanen M; Dam M; Yuen AW
    Epilepsy Res; 1996 Mar; 23(2):149-55. PubMed ID: 8964276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group.
    Brodie MJ; Richens A; Yuen AW
    Lancet; 1995 Feb; 345(8948):476-9. PubMed ID: 7710545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy.
    Pack AM; Morrell MJ; Randall A; McMahon DJ; Shane E
    Neurology; 2008 Apr; 70(18):1586-93. PubMed ID: 18443309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Lamotrigine in add-on therapy: assessment of efficacy in drug resistant epilepsy].
    Juryńczyk J; Weglewski A
    Neurol Neurochir Pol; 2000; 34(1):43-7. PubMed ID: 10849903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monostars: an aid to choosing an antiepileptic drug as monotherapy.
    Brodie MJ
    Epilepsia; 1999; 40 Suppl 6():S17-22; discussion S73-4. PubMed ID: 10530678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lamotrigine for the treatment of epilepsy in childhood.
    Besag FM; Wallace SJ; Dulac O; Alving J; Spencer SC; Hosking G
    J Pediatr; 1995 Dec; 127(6):991-7. PubMed ID: 8523205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seizure control with antiepileptic drug therapy in 517 consecutive adult outpatients at the Kork Epilepsy Centre.
    Steinhoff BJ; Maren Staack A; Wisniewski I
    Epileptic Disord; 2012 Dec; 14(4):379-87. PubMed ID: 23274162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The tolerability of lamotrigine in elderly patients with epilepsy.
    Giorgi L; Gomez G; O'Neill F; Hammer AE; Risner M
    Drugs Aging; 2001; 18(8):621-30. PubMed ID: 11587248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Lamotrigine in the therapy of resistant epilepsy].
    De Romanis F; Sopranzi N
    Clin Ter; 1999; 150(4):279-82. PubMed ID: 10605165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lamotrigine. A review of its pharmacological properties and clinical efficacy in epilepsy.
    Goa KL; Ross SR; Chrisp P
    Drugs; 1993 Jul; 46(1):152-76. PubMed ID: 7691504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbamazepine, but not valproate, displays pharmacoresistance in lamotrigine-resistant amygdala kindled rats.
    Srivastava AK; White HS
    Epilepsy Res; 2013 Mar; 104(1-2):26-34. PubMed ID: 23158096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparative assessment of treatment efficacy with lamotrigine (Lamictal) together with valproate and/or carbamazepine in patients with refractory epilepsy].
    Wierzba W; Wajgt A
    Neurol Neurochir Pol; 1997; 31(6):1133-46. PubMed ID: 9591300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical efficacy of lamotrigine as an antiepileptic drug.
    Pellock JM
    Neurology; 1994 Nov; 44(11 Suppl 8):S29-35. PubMed ID: 7970004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epilepsy and antiepileptic drug therapy in juvenile neuronal ceroid lipofuscinosis.
    Aberg LE; Bäckman M; Kirveskari E; Santavuori P
    Epilepsia; 2000 Oct; 41(10):1296-302. PubMed ID: 11051125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lamotrigine. A review of its use in childhood epilepsy.
    Culy CR; Goa KL
    Paediatr Drugs; 2000; 2(4):299-330. PubMed ID: 10946418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lamotrigine extended-release as adjunctive therapy with optional conversion to monotherapy in older adults with epilepsy.
    Wechsler RT; Leroy R; Van Cott A; Hammer AE; Vuong A; Huffman R; VanLandingham K; Messenheimer JA
    Epilepsy Res; 2014 Aug; 108(6):1128-36. PubMed ID: 24888248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lamotrigine for patients with juvenile myoclonic epilepsy following prior treatment with valproate: results of an open-label study.
    Morris GL; Hammer AE; Kustra RP; Messenheimer JA
    Epilepsy Behav; 2004 Aug; 5(4):509-12. PubMed ID: 15256187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of monotherapy with lamotrigine or carbamazepine in patients with newly diagnosed partial epilepsy.
    Nieto-Barrera M; Brozmanova M; Capovilla G; Christe W; Pedersen B; Kane K; O'Neill F;
    Epilepsy Res; 2001 Aug; 46(2):145-55. PubMed ID: 11463516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An active-control trial of lamotrigine monotherapy for partial seizures.
    Gilliam F; Vazquez B; Sackellares JC; Chang GY; Messenheimer J; Nyberg J; Risner ME; Rudd GD
    Neurology; 1998 Oct; 51(4):1018-25. PubMed ID: 9781523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.